Content | Test bank for Pharmacology 9th Edition Linda McCuistion
Table of Contents
UNIT ONE: Introduction to Pharmacology
1. Drug Development and Ethical Considerations
2. Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
3. Cultural Considerations
4. Complementary and Alternative Therapies
5. Pediatric Considerations
6. Geriatric Considerations
7. Drugs in Substance Use Disorder
UNIT TWO: Pharmacotherapy and Drug Administration
8. The Nursing Process and Patient-Centered Care
9. Safety and Quality
10. Drug Administration
11. Drug Calculations
UNIT THREE: Maintenance of Homeostasis
12. Fluid Volume and Electrolytes
13. Vitamin and Mineral Replacement
14. Nutritional Support
UNIT FOUR: Autonomic Nervous System Drugs
15. Adrenergic Agonists and Antagonists
16. Cholinergic Agonists and Antagonists
UNIT FIVE: Central and Peripheral Nervous System Drugs
17. Stimulants
18. Depressants
19. Antiseizure Drugs
20. Drugs for Parkinsonism and Alzheimer’s Disease
21. Drugs for Neuromuscular Disorders and Muscle Spasms
UNIT SIX: Mental and Behavioral Health Drugs
22. Antipsychotics and Anxiolytics
23. Antidepressants and Mood Stabilizers
UNIT SEVEN: Pain and Inflammation Management Drugs
24. Antiinflammatories
25. Analgesics
UNIT EIGHT: Antimicrobial Drugs
26. Antibacterials
27. Antituberculars, Antifungals, and Antivirals
28. Peptides, Antimalarials, and Anthelmintics
UNIT NINE: Immunologic Drugs
29. HIV- and AIDS-Related Drugs
30. Transplant Drugs
31. Vaccines
UNIT TEN: Antineoplastics and Biologic Response Modifiers
32. Anticancer Drugs
33. Targeted Therapies to Treat Cancer
34. Biologic Response Modifiers
UNIT ELEVEN: Respiratory Drugs
35. Upper Respiratory Disorders
36. Lower Respiratory Disorders
UNIT TWELVE: Cardiovascular Drugs
37. Cardiac Glycosides, Antianginals, and Antidysrhythmics
38. Diuretics
39. Antihypertensives
40. Anticoagulants, Antiplatelets, and Thrombolytics
41. Antihyperlipidemics and Peripheral Vasodilators
UNIT THIRTEEN: Gastrointestinal Drugs
42. Gastrointestinal Tract Disorders
43. Antiulcer Drugs
UNIT FOURTEEN: Eye, Ear, and Skin Drugs
44. Eye and Ear Disorders
45. Dermatologic Disorders
UNIT FIFTEEN: Endocrine Drugs
46. Pituitary, Thyroid, Parathyroid, and Adrenal Disorders
47. Antidiabetics
UNIT SIXTEEN: Renal and Urologic Drugs
48. Urinary Disorders
UNIT SEVENTEEN: Reproductive and Gender-Related Drugs
49. Pregnancy and Preterm Labor
50. Labor, Delivery, and Postpartum
51. Neonatal and Newborn 52. Women’s Reproductive Health
53. Men’s Reproductive Health
54. Sexually Transmitted Infections
UNIT EIGHTEEN: Emergency Drugs
55. Adult and Pediatric Emergency Drugs | Test Bank Pharmacology for the Surgical Technologist, 4th Edition by Katherine Snyder
Chapter 01: Basic Pharmacology
MULTIPLE CHOICE
- A drug that binds to a receptor and stimulates its function is said to be a(n) drug.
- agonist
- antagonist
- idiosyncratic
- pharmacokinetic
ANS: A
Agonist drugs bind to or have an affinity (attraction) for a receptor and cause a particular response.
DIF: 1 REF: 14 TOP: AST Core Curriculum X:B:1:b, agonist
- Which one of the following is not used for the classification of drugs?
- Therapeutic action
- Physiologic action
- Affected body system
- Source of origin
ANS: D
Drugs are classified by what they do, what they affect, what they are not, and where they come from.
DIF: 1 REF: 4 TOP: AST Core Curriculum X:B:2, therapeutic actions
- An anticoagulant drug is classified by its
- chemical type.
- source of origin.
- physiologic action.
- therapeutic action.
ANS: D
Therapeutic action describes what the drug does for a patient; in this example, it works against coagulation.
DIF: 1 REF: 4 TOP: AST Core Curriculum X:B:2:a, indications
- Prescriptions must include all of the following information except
- the name of the drug.
- patient’s social security number.
- drug dosage.
- route of administration of the drug.
ANS: B
Prescriptions must include the date, name of the patient, name of the drug, dosage, route of administration, and frequency or time of administration. The patient’s social security number will be in the chart but not on a prescription.
DIF: 1 REF: 5
TOP: AST Core Curriculum XI: B:2, prescription medications
- An order for a drug to be given as needed is called an order.
- standing
- oral
- stat
- PRN
ANS: D
PRN stands for pro re nata, which means that the drug may be given as needed.
DIF: 1 REF: 5 TOP: AST Core Curriculum XI:D:3:d, PRN
- What does the abbreviation so mean on a prescription?
- One half
- Once, if necessary
- Without
- As desired
ANS: B
sos means once, if necessary (see Table 1-3).
DIF: 1 REF: 5
TOP: AST Core Curriculum XI:B:2, prescription medications
- How is an order for a drug to be taken every 4 hours indicated on a prescription?
- q4h
- qid
- qod
- qs
ANS: A
The q means every; the actual number of hours is inserted before the h, which means hours.
DIF: 3 REF: 7
TOP: AST Core Curriculum XI:B:2, prescription medications
- How is an order for a drug to be given three times a day indicated on a prescription?
- q3h
- hs
- qh
- tid
ANS: D
tid means three times a day (see Table 1-4).
DIF: 1 REF: 7
TOP: AST Core Curriculum XI:B:2, prescription medications
- Which form of drug preparation tends to act more quickly?
- Solid
- Semisolid
- Liquid
- Gas
ANS: D
Absorption of drugs given by inhalation is rapid, especially gases such as inhalation anesthetics, because of the huge numbers of capillaries in the alveoli of the lungs.
DIF: 2 REF: 7 TOP: AST Core Curriculum XI:G:1, gas
- Which one of the following abbreviations indicates an ointment form of a given drug?
- gtts
- ung
- susp
- soln
ANS: B
ung means ointment.
DIF: 1 REF: 8 TOP: AST Core Curriculum XI:G:4, semisolid
- Which one of the following abbreviations indicates that a drug is to be given orally?
- IM
- PO
- IV
- SC
ANS: B
PO means per os or by mouth.
DIF: 1 REF: 9 TOP: AST Core Curriculum XI:H:4, PO
- How is a medication administered by any route except the mouth?
- Systemically
- Sublingually
- Parenterally
- Subcutaneously
ANS: C
The term parenteral indicates any route other than the digestive tract.
DIF: 3 REF: 9 TOP: AST Core Curriculum XI:H:1, injection/parenteral
- Which one of the following terms is the study of the four basic processes of absorption, distribution, metabolism, and excretion in response to drugs?
- Pharmacokinetics
- Pharmacodynamics
- Biotransformation
- Sympathomimetics
ANS: A
The study of pharmacokinetics focuses on how the body processes drugs.
DIF: 1 REF: 11 TOP: AST Core Curriculum X:A:2, pharmacokinetics
- Distribution of drugs within the body is carried out through which one of the following body systems?
- Respiratory
- Circulatory
- Integumentary
- Urinary
ANS: B
Once a drug has been absorbed into the bloodstream, it is transported throughout the body by the circulatory system. Drug molecules eventually diffuse out of the bloodstream to the site of action in the process called distribution.
DIF: 2 REF: 12 TOP: AST Core Curriculum X:A:2:b, distribution
- The time between the administration of a drug and the first appearance of its effects is called
- peak effect.
- onset.
- duration.
- reaction time.
ANS: B
The time between the administration of a drug and the first appearance of effects is called the onset.
DIF: 1 REF: 15 TOP: AST Core Curriculum X:A:3:a, onset
- Which group of drugs is known as receptor blockers?
- Antagonists
- Agonists
- Antipyretics
- Analgesics
ANS: A
Drugs that bind to a receptor and prevent a response are called antagonists (Fig. 1-11). Antagonists are also called receptor blockers.
DIF: 2 REF: 14 TOP: AST Core Curriculum X:B:1:c, antagonist
- An expected but unintended effect of a drug is termed a(n) effect.
- idiosyncratic
- adverse
- synergic
- side
ANS: D
| Test Bank for Patient-Centered Pharmacology Learning System for the Conscientious Prescriber 1st Edition by Tindall
Chapter 1. Conscientious and Rational Prescribing in the 21st Century
Multiple Choice
Identify the choice that best completes the statement or answers the question.
____ 1. Which statement regarding herbals, vitamins, minerals, and food supplements is true?
A. |
Herbals, vitamins, minerals, and food supplements are not regulated by the U.S. Food, Drug, and Cosmetic Act (FDCA). |
B. |
Manufacturers must prove the safety of their herbals, vitamins, minerals, and food supplements. |
C. |
Manufacturers must prove that their herbals, vitamins, minerals, and food supplements are free from adulteration. |
D. |
Manufacturers must prove the legitimacy of any claims they make about their herbals, vitamins, minerals, and food supplements. |
____ 2. Which amendment to the FDCA established the two classes of drugs: legend or prescription only and over the counter?
A. |
Durham-Humphrey Amendment (Prescription Drug Amendment) |
B. |
New Drug Application Amendment |
C. |
Health Education and Welfare Amendment |
D. |
Kefauer Harris Amendment |
____ 3. The package insert (PI) attached to a prescription drug contains all of the following information except:
A. |
U.S. Food and Drug Administration (FDA)-approved drug information. |
B. |
Highly detailed adverse effects and dosage information for the prescriber. |
C. |
Information in layman’s terms for the patient. |
D. |
Pharmacodynamic and pharmacokinetic drug information. |
____ 4. Which of the following best defines the term adulteration of drugs?
A. |
Adding contaminants or anything not stated on a drug label |
B. |
Claiming a drug is a cure for a certain condition, such as cancer |
C. |
Advertising a drug for a poorly defined condition, such as miasma |
D. |
Claiming a drug is safe when its safety has not been established in preclinical trials |
____ 5. The majority of “off-label” or unapproved usages for drugs are prescribed for which patient groups?
A. |
Pediatric patients and patients on chemotherapy |
B. |
Patients with neurologic diseases |
C. |
Obese patients |
D. |
Pregnant patients |
____ 6. The major goals of the Controlled Substances Act (CSA) include all of the following except:
A. |
Improving the manufacturing, distribution, prescribing, and dispensing of controlled substances by legitimate persons in the health-care sector. |
B. |
Providing research into issues of drug addiction and rehabilitation. |
C. |
Stopping the widespread diversion of controlled substances into illicit or “street” channels. |
D. |
Establishing laws and criminal sentences for the possession and sale of illicit controlled substances. |
____ 7. Which statement is true regarding the Drug Enforcement Administration (DEA) categories of scheduled drugs?
A. |
Schedule I drugs have a high potential for abuse and no accepted medical use in the United States. |
B. |
Schedule I drugs have a low potential for abuse and no accepted medical use in the United States. |
C. |
Schedule II drugs have a low potential for abuse. |
D. |
Schedule V drugs have a high potential for abuse. |
____ 8. Which statement regarding extemporaneous compounding is false?
A. |
Extemporaneous compounding is the pharmacist’s art of preparing a drug product for a specific patient using a physician’s prescription, a drug formula, or a recipe. |
B. |
Calculated amounts of ingredients are measured out and made into a uniform mixture. |
C. |
Extemporaneous compounding is the pharmacist’s art of preparing a drug product for a patient using his own drug formula rather than a physician’s prescription. |
D. |
Pediatric dosages are commonly compounded when only adult dosages are available. |
____ 9. Clinical pharmacology is best defined as:
A. |
The study of the optimum use of medication in patients. |
B. |
The study of the human body’s reaction to a drug over a specified time. |
C. |
The biologic actions of a drug at its site of action. |
D. |
The study of the effects of genetic variations on pharmacologic processes. |
____ 10. Which statement regarding over-the-counter (OTC) drugs is true?
A. |
OTC drugs are rarely associated with toxicity or overdose. |
B. |
No OTC drugs are also available in a higher dosage form by prescription. |
C. |
OTC drugs are generally more expensive than prescription drugs. |
D. |
OTC drugs contain directions and information on the label and packaging to allow consumers to self-medicate. |
____ 11. In the early 1960s, the serious birth defects caused by thalidomide prompted which of the following amendments to the FDCA?
A. |
Kefauver Harris Drug Efficacy Amendment |
B. |
Dietary Supplement and Health Act |
C. |
Orphan Drug Status Act |
D. |
Controlled Substances Act |
____ 12. Which medication is an example of a schedule I (C-I) drug?
A. |
oxycodone |
B. |
mescaline |
C. |
fentanyl |
D. |
diazepam |
____ 13. Which statement regarding schedule II (C-II) controlled substance drugs is true?
A. |
Heroin is an example of a schedule II drug. |
B. |
Prescribers can write orders that include up to five refills of schedule II prescription drugs. |
C. |
Cough syrup with codeine is an example of a schedule II drug. |
D. |
Emergency verbal orders for a schedule II drug must be confirmed with a written prescription within 72 hours. |
____ 14. According to the Centers for Disease Control and Prevention, the number of preventable medical errors per year is approximately:
A. |
100,000. |
B. |
25,000. |
C. |
1 million. |
D. |
500,000. |
____ 15. Adverse drug events:
A. |
Occur once a day in every hospital in the United States. |
B. |
Do not increase health care-related costs. |
C. |
Are less common among Medicare patients. |
D. |
Are not common among residents in a long-term care facility. |
____ 16. In 1994, the World Health Organization (WHO) released recommendations for rational prescribing that included all of the following recommendations except:
A. |
Use only brand (trade) name drugs. |
B. |
Ensure medication choices are safe and effective for the defined problem. |
C. |
Monitor the results of treatment. |
D. |
Stop the use of a drug when the treatment period is complete. |
____ 17. Which statement is true regarding medication errors?
A. |
Telephone communication of drug orders decreases the frequency of medication errors. |
B. |
Mail order medications are less likely to cause issues with medication errors. |
C. |
Lack of patient history information is a common source of medication errors. |
D. |
Patient education regarding medications should be left to the pharmacist to avoid medication errors. |
____ 18. Which statement is true regarding medication errors?
A. |
They are most commonly the result of a single event. |
B. |
They are most commonly the result of multiple events. |
C. |
They are usually caused by a single careless person. |
D. |
A faulty system will not contribute to medication errors. |
____ 19. The “Signa,” or signatura, component of a written prescription includes:
A. |
Patient data, such as age, name, and gender. |
B. |
Prescriber data, such as name, practice location and phone number, and professional degree. |
C. |
Instructions the prescriber has given to the patient, which will appear on medication label. |
D. |
Brand or generic name and strength of medication. |
____ 20. Which of the following examples could be the inscription component on a prescription?
A. |
John Smith, RPA-C, License number |
B. |
Dispense # 20 |
C. |
Cefuroxime 500 mg |
D. |
Take one tablet PO twice daily for 10 days |
____ 21. Which of the following examples could be the subscription component on a prescription?
A. |
Dispense # 100 ml |
B. |
John Smith, RPA-C, License number |
C. |
Patient name and address |
D. |
Take 5 ml PO twice daily for 10 days |
____ 22. A prescriber wants a patient to receive the Dilantin brand and does not wish to substitute with the generic, phenytoin. Which of the following statements is false regarding generic and brand substitution?
A. |
The Drug Substitution Law allows a pharmacist to substitute a generic bioequivalent drug for one stated on a prescription. |
B. |
A prescriber can write “DAW,” meaning “dispense as written,” to ensure that a patient receives the brand name drug. |
C. |
The FDA regulates and reports on bioequivalence testing for generic drugs. |
D. |
All brand drugs can be switched to generic without biologically significant fluctuations. |
____ 23. Which abbreviation indicates that a patient should take their medication at bedtime?
A. |
HS |
B. |
BID |
C. |
AC |
D. |
PRN |
____ 24. A patient is instructed to apply one drop to each eye. Which abbreviation for these instructions is accurate?
A. |
One gtt ou |
B. |
One gr ad |
C. |
One gtt au |
D. |
One gtt od |
____ 25. Which abbreviation indicates that a medication should be taken by mouth twice daily?
A. |
po BID |
B. |
po ac |
C. |
po qd |
D. |
po TIW |
____ 26. Which abbreviation indicates that three drops should be placed in both ears?
A. |
Three gtt as |
B. |
Three gtt ad |
C. |
Three gtt au |
D. |
Three gtt od |
|
Chapter 01: Drug Definitions, Standards, and Information Sources
Willihnganz: Clayton’s Basic Pharmacology for Nurses, 18th Edition
MULTIPLE CHOICE
1.What is the name under which a drug is listed by the US Food and Drug Administration (FDA)?
a. |
Brand |
b. |
Nonproprietary |
c. |
Official |
d. |
Trademark |
ANS: C
The official name is the name under which a drug is listed by the FDA. The brand name, or trademark, is the name given to a drug by its manufacturer. The nonproprietary, or generic, name is provided by the United States Adopted Names Council
DIF: Cognitive Level: Knowledge REF: p. 2 OBJ: 1
NAT: NCLEX Client Needs Category: Safe, Effective Care Environment
TOP: Nursing Process Step: Assessment CON: Patient Education
- Which source contains information specific to nutritional supplements?
a. |
USP Dictionary of USAN & International Drug Names |
b. |
Natural Medicines Comprehensive Database |
c. |
United States Pharmacopoeia/National Formulary (USP NF) |
d. |
Drug Interaction Facts |
ANS: C
United States Pharmacopoeia/National Formulary contains information specific to nutritional supplements. USP Dictionary of USAN & International Drug Names is a compilation of drug names, pronunciation guide, and possible future FDA approved drugs; it does not include nutritional supplements. Natural Medicines Comprehensive Database contains evidence-based information on herbal medicines and herbal combination products; it does not include information specific to nutritional supplements. Drug Interaction Facts contains comprehensive information on drug interaction facts; it does not include nutritional supplements.
DIF: Cognitive Level: Knowledge REF: p. 2 | p. 3 OBJ: 3
NAT: NCLEX Client Needs Category: Physiological Integrity
TOP: Nursing Process Step: Assessment CON: Nutrition | Patient Education
3.What is the most comprehensive reference available to research a drug interaction?
a. |
Drug Facts and Comparisons |
b. |
Drug Interaction Facts |
c. |
Handbook on Injectable Drugs |
d. |
Martindale—The Complete Drug Reference |
ANS: B
First published in 1983, Drug Interaction Facts is the most comprehensive book available on drug interactions. In addition to monographs listing various aspects of drug interactions, this information is reviewed and updated by an internationally renowned group of physicians and pharmacists with clinical and scientific expertise.
DIF: Cognitive Level: Comprehension REF: p. 4 OBJ: 3
NAT: NCLEX Client Needs Category: Physiological Integrity
TOP: Nursing Process Step: Assessment CON: Safety | Patient Education | Clinical Judgment
4.The physician has written an order for a drug with which the nurse is unfamiliar. Which section of the Physicians’ Desk Reference (PDR) is most helpful to get information about this drug?
a. |
Manufacturer’s section |
b. |
Brand and Generic name section |
c. |
Product category section |
d. |
Product information section |
ANS: B
A physician’s order would include the brand and/or generic name of the drug. The alphabetic index in the PDR would make this section the most user-friendly. Based on a physician’s order, manufacturer’s information and classification information would not be known. The Manufacturer’s section is a roster of manufacturers. The product category section lists products subdivided by therapeutic classes, such as analgesics, laxatives, oxytocics, and antibiotics. The product information section contains reprints of the package inserts for the major products of manufacturers.
DIF: Cognitive Level: Comprehension REF: p. 4 OBJ: 3
NAT: NCLEX Client Needs Category: Physiological Integrity
TOP: Nursing Process Step: Planning CON: Safety | Patient Education | Clinical Judgment
5.Which online drug reference makes available to healthcare providers and the public a standard, comprehensive, up-to-date look up and downloadable resource about medicines?
a. |
American Drug Index |
b. |
American Hospital Formulary |
c. |
DailyMed |
d. |
Physicians’ Desk Reference (PDR) |
ANS: C
DailyMed makes available to healthcare providers and the public a standard, comprehensive, up-to-date look up and downloadable resource about medicines. The American Drug Index is not appropriate for patient use. The American Hospital Formulary is not appropriate for patient use. The PDR is not appropriate for patient use.
DIF: Cognitive Level: Knowledge REF: p. 3 | p. 5 OBJ: 4
NAT: NCLEX Client Needs Category: Physiological Integrity
TOP: Nursing Process Step: Implementation
CON: Safety | Patient Education | Clinical Judgment
6.Which legislation authorizes the FDA to determine the safety of a drug before its marketing?
a. |
Federal Food, Drug, and Cosmetic Act (1938) |
b. |
Durham Humphrey Amendment (1952) |
c. |
Controlled Substances Act (1970) |
d. |
Kefauver Harris Drug Amendment (1962) |
ANS: A
The Federal Food, Drug, and Cosmetic Act of 1938 authorized the FDA to determine the safety of all drugs before marketing. Later amendments and acts helped tighten FDA control and ensure drug safety. The Durham Humphrey Amendment defines the kinds of drugs that cannot be used safely without medical supervision and restricts their sale to prescription by a licensed practitioner. The Controlled Substances Act addresses only controlled substances and their categorization. The Kefauver Harris Drug Amendment ensures drug efficacy and greater drug safety. Drug manufacturers are required to prove to the FDA the effectiveness of their products before marketing them.
DIF: Cognitive Level: Knowledge REF: p. 5 OBJ: 6
NAT: NCLEX Client Needs Category: Physiological Integrity
TOP: Nursing Process Step: Assessment
CON: Safety | Patient Education | Evidence | Health Care Law
7.Meperidine (Demerol) is a narcotic with a high potential for physical and psychological dependency. Under which classification does this drug fall?
ANS: B
Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse and may lead to severe psychological and physical dependence. Schedule I drugs have high potential for abuse and no recognized medical use. Schedule III drugs have some potential for abuse. Use may lead to low to moderate physical dependence or high psychological dependence. Schedule IV drugs have low potential for abuse. Use may lead to limited physical or psychological dependence.
DIF: Cognitive Level: Comprehension REF: p. 5 OBJ: 2
NAT: NCLEX Client Needs Category: Safe, Effective Care Environment
TOP: Nursing Process Step: Assessment CON: Patient Education | Addiction | Pain
8:What would the FDA do to expedite drug development and approval for an outbreak of smallpox, for which there is no known treatment?
a. |
List smallpox as a health orphan disease. |
b. |
Omit the preclinical research phase. |
c. |
Extend the clinical research phase. |
d. |
Fast track the investigational drug. |
ANS: D | Test Bank for Pharmacology and the Nursing Process 9th Edition
Contents
Chapter 01: The Nursing Process and Drug Therapy................................................................................. 4
Chapter 02: Pharmacologic Principles...................................................................................................... 8
Chapter 03: Lifespan Considerations...................................................................................................... 14
Chapter 04: Cultural, Legal, and Ethical Considerations.......................................................................... 20
Chapter 05: Medication Errors: Preventing and Responding .................................................................. 26
Chapter 06: Patient Education and Drug Therapy................................................................................... 29
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements ........................................... 34
Chapter 08: Gene Therapy and Pharmacogenomics............................................................................... 38
Chapter 09: Photo Atlas of Drug Administration .................................................................................... 41
Chapter 10: Analgesic Drugs.................................................................................................................. 50
Chapter 11: General and Local Anesthetics............................................................................................ 57
Chapter 12: Central Nervous System Depressants and Muscle Relaxants............................................... 61
Chapter 13: Central Nervous System Stimulants and Related Drugs....................................................... 66
Chapter 14: Antiepileptic Drugs............................................................................................................. 70
Chapter 15: Antiparkinson Drugs.............................................................................................................76
Chapter 16: Psychotherapeutic Drugs.................................................................................................... 81
Chapter 17: Substance Use Disorder...................................................................................................... 88
Chapter 18: Adrenergic Drugs................................................................................................................ 93
Chapter 19: Adrenergic-Blocking Drugs.................................................................................................. 98
Chapter 20: Cholinergic Drugs ............................................................................................................. 103
Chapter 21: Cholinergic-Blocking Drugs............................................................................................... 108
Chapter 22: Antihypertensive Drugs.................................................................................................... 113
Chapter 23: Antianginal Drugs............................................................................................................. 119
Chapter 24: Heart Failure Drugs........................................................................................................... 125
Chapter 25: Antidysrhythmic Drugs..................................................................................................... 131
Chapter 26: Coagulation Modifier Drugs.............................................................................................. 137
Chapter 27: Antilipemic Drugs............................................................................................................. 143
Chapter 28: Diuretic Drugs................................................................................................................... 148
Chapter 29: Fluids and Electrolytes...................................................................................................... 154
Chapter 30: Pituitary Drugs.................................................................................................................. 160
Chapter 31: Thyroid and Antithyroid Drugs.......................................................................................... 163
Chapter 32: Antidiabetic Drugs............................................................................................................ 168
Chapter 33: Adrenal Drugs................................................................................................................... 177
Chapter 34: Women’s Health Drugs..................................................................................................... 181
Chapter 35: Men’s Health Drugs.......................................................................................................... 188
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants ....................................... 193
Chapter 37: Respiratory Drugs............................................................................................................. 198
Chapter 38: Antibiotics Part 1.............................................................................................................. 204
Chapter 39: Antibiotics Part 2.............................................................................................................. 211
Chapter 40: Antiviral Drugs.................................................................................................................. 216
Chapter 41: Antitubercular Drugs ........................................................................................................ 221
Chapter 42: Antifungal Drugs............................................................................................................... 226
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ........................................................ 231
Chapter 44: Anti-inflammatory and Antigout Drugs............................................................................. 236
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs..................... 242
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs......... 248
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs ................................................... 253
Chapter 48: Immunosuppressant Drugs............................................................................................... 258
Chapter 49: Immunizing Drugs............................................................................................................. 263
Chapter 50: Acid-Controlling Drugs...................................................................................................... 268
Chapter 51: Bowel Disorder Drugs....................................................................................................... 274
Chapter 52: Antiemetic and Antinausea Drugs..................................................................................... 281
Chapter 53: Vitamins and Minerals...................................................................................................... 286
Chapter 54: Anemia Drugs................................................................................................................... 292
Chapter 55: Nutritional Supplements................................................................................................... 299
Chapter 56: Dermatologic Drugs.......................................................................................................... 304
Chapter 57: Ophthalmic Drugs............................................................................................................. 310
Chapter 58: Otic Drugs ............................ | McCuistion: Pharmacology: A Patient-Centered Nursing Process Approach, 9th Edition
Chapter 04: Complementary and Alternative Therapies
MULTIPLE CHOICE
- A family member expresses concern that a patient is taking several herbal remedies and worries that they may be unsafe. The nurse will respond by saying that herbs
a. |
are classified as medications by the Dietary Supplement Health and Education Act of 1994. |
b. |
are regulated by the government and are determined to be safe. |
c. |
aren’t usually effective but are generally harmless. |
d. |
should be discussed with the patient’s provider in conjunction with other medications. |
ANS: D
Herbs are sometimes useful but can also be useless or dangerous. There are two types of monographs under development to compile information about these substances, but there are no agencies that regulate safety and efficacy. Patients should always tell providers if they are taking any herbal remedies since there are known drug–herbal interactions and side effects.
DIF: Cognitive Level: Applying (Application) REF: p. 41
TOP: Nursing Process: Nursing Intervention: Patient Teaching
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
- A pregnant woman tells the nurse that she is taking ginger to reduce morning sickness. What will the nurse tell this patient?
a. |
“Ginger can cause fetal birth defects.” |
b. |
“Ginger is not safe during pregnancy.” |
c. |
“Ginger can cause abortion in low doses.” |
d. |
“Ginger may be taken in low doses for up to 4 days.” |
ANS: D
Ginger may be taken during pregnancy for morning sickness, but only on a short-term, low-dose basis. There is no indication that it causes fetal birth defects. Ginger is an abortifacient in large amounts.
DIF: Cognitive Level: Applying (Application) REF: p. 39
TOP: Nursing Process: Nursing Intervention: Patient Teaching
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
- A patient asks the nurse about a herbal supplement and reports that it has a United States Pharmacopeia (USP) seal of approval. The nurse explains that this indicates
a. |
identity, potency, purity, and labeling accuracy. |
b. |
premarket testing for safety and efficacy. |
c. |
structure and function claims may be made. |
d. |
the supplement’s ability to prevent and treat disease. |
ANS: A
The USP “seal of approval” is a fee-based test and reports on identity, potency, purity, and labeling accuracy. It does not indicate premarket research on safety and accuracy, does not allow manufacturers to make claims about the function of the products, and does not indicate the substance’s ability to prevent and treat disease.
DIF: Cognitive Level: Applying (Application) REF: p. 38
TOP: Nursing Process: Nursing Intervention: Patient Teaching
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
- A woman reports using ginseng to treat menopausal symptoms. Which response by the nurse is correct?
a. |
“Ginseng will inhibit your immune system.” |
b. |
“Please tell me if you are taking diabetic medications.” |
c. |
“Side effects of ginseng are common.” |
d. |
“You may experience a decrease in blood pressure while taking ginseng.” |
ANS: B
Diabetic patients taking ginseng should consult with their provider if used in conjunction with other herbs or drugs, because hypoglycemia may result. It may boost the immune system. Side effects are rare except with long-term use or in large doses. Ginseng can increase blood pressure.
DIF: Cognitive Level: Applying (Application) REF: p. 40
TOP: Nursing Process: Assessment/Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
- A woman who is experiencing symptoms of heart failure asks the nurse about using hawthorn. Which response by the nurse is correct?
a. |
“Hawthorn may be used long term in conjunction with nitrates.” |
b. |
“Hawthorn may contribute to hypertension.” |
c. |
“Hawthorn may interact with antihypertensive drugs.” |
d. |
“Hawthorn treats heart failure by lowering potassium levels.” |
ANS: C
Hawthorn may increase the action of antihypertensive medications. Its efficacy is not conclusive and it may interact with nitrates. It may decrease blood pressure. There is no evidence that hawthorn lowers potassium levels.
DIF: Cognitive Level: Applying (Application) REF: p. 40
TOP: Nursing Process: Nursing Intervention: Patient Teaching
MSC: NCLEX: Physiological Integrity: Reduction of Risk Potential
- A patient who has HIV asks the nurse about taking Echinacea to improve immune function. What will the nurse tell this patient?
a. |
“The root extract is useful for treating upper respiratory and urinary tract infections.” |
b. |
“Research regarding the benefits of Echinacea is inconclusive.” |
c. |
“Use it as needed when antibiotics fail to treat your infections.” |
d. |
“You may use it safely up to 8 weeks at a time as a preventive medication.” |
ANS: B
Research regarding the benefits of Echinacea as treatment for cold and flu symptoms is inconclusive. The use of Echinacea to stimulate the immune system of patients with HIV is being investigated, but its use is currently not recommended.
DIF: Cognitive Level: Applying (Application) REF: p. 39
TOP: Nursing Process: Nursing Intervention: Patient Teaching
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
- The nurse is counseling a female patient who reports taking ginger to treat postoperative nausea. Which statement by the patient indicates understanding of the teaching?
a. |
“I should experience immediate effects with this herb.” |
b. |
“The benefits of taking ginger for postoperative nausea have not been proven.” |
c. |
“I should take ginger with nonsteroidal antiinflammatory drugs (NSAIDs) to enhance its effects.” |
d. |
“If I develop gastrointestinal (GI) upset, I should stop taking ginger immediately.” |
ANS: B
The benefits of taking ginger for postoperative nausea have not been proven, as they have been used short-term for the treatment of nausea associated with pregnancy. Patients may not experience immediate effects. Patients should not take ginger with NSAIDs without consulting the provider. GI upset (gas, bloating, heartburn) are common side effects of the herb.
DIF: Cognitive Level: Applying (Application) REF: p. 39
TOP: Nursing Process: Nursing Intervention: Patient Teaching
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
- The nurse is providing preoperative education to a patient who will have surgery in several weeks. The patient denies taking anticoagulant medications but reports using herbal supplements. Which herb would cause the nurse to be concerned?
a. |
Echinacea |
b. |
Ginkgo biloba |
c. |
Kava |
d. |
Sage |
ANS: B
Ginkgo can prolong bleeding time and therefore should be discontinued 2 weeks prior to surgery.
DIF: Cognitive Level: Applying (Application) REF: p. 40
TOP: Nursing Process: Nursing Intervention: Patient Teaching
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
- The nurse provides counseling to a patient who reports taking licorice root to treat a stomach ulcer. Which statement by the patient indicates understanding of the teaching?
a. |
“I may take licorice root with prednisone.” |
b. |
“I may develop hypotension while taking licorice root.” |
c. |
“I should avoid licorice root when pregnant.” |
d. |
“I should try licorice instead of coming back to see the provider.” |
ANS: C
In large amounts, licorice root has been associated with preterm labor and should be avoided in women who are pregnant. Licorice root when taken with corticosteroids can lead to life-threatening hypokalemia. In large amounts, it can elevate blood pressure. The benefits of licorice in the treatment of any condition have not been proven, and the client should see the provider rather than turn to the herbal medication.
DIF: Cognitive Level: Applying (Application) REF: p. 40
TOP: Nursing Process: Nursing Intervention: Patient Teaching
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
- The spouse of a patient who is an alcoholic asks the nurse about dietary supplements that may help prevent liver disease. Which herb will the nurse suggest the patient discuss with a provider who has prescriptive authority?
a. |
Ginkgo biloba |
b. |
Kava |
c. |
Milk thistle |
d. |
Sage |
ANS: C
Milk thistle can prevent damage to liver cells and stimulates regeneration of liver cells.
DIF: Cognitive Level: Understanding (Comprehension) REF: p. 40
TOP: Nursing Process: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
- A patient reports taking St. John’s wort to treat symptoms of depression and asks the nurse how to use this product safely and effectively. Which response by the nurse is correct?
a. |
“Apply sunscreen while taking St. John’s wort.” |
b. |
“It is safe to take St. John’s wort with prescription antidepressants.” |
c. |
“St. John’s wort does not affect nutrition.” |
d. |
“You should take St. John’s wort as needed when symptoms occur.” |
ANS: A
St. John’s wort can cause photosensitivity, so patients should be counseled to use sunscreen. It should not be taken with prescription antidepressants because it increases the risk of suicidal ideation. It interferes with the absorption of iron and other minerals. Effects do not occur for 4 to 8 weeks, so it cannot be taken as needed.
DIF: Cognitive Level: Applying (Application) REF: p. 40
TOP: Nursing Process: Nursing Intervention: Patient Teaching
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
- A patient is taking valerian, or “herbal valium,” to induce sleep. What will the nurse teach this patient about this herb?
a. |
Habituation and addiction are likely. |
b. |
Hangover effects are common with usual doses. |
c. |
Liver function tests must be monitored with long-term use. |
d. |
Valerian has a high risk for overdose. |
ANS: C
Liver function tests must be monitored with long-term use, and valerian should be discontinued if these are elevated. Habituation and addiction are rare. Hangover effects occur with high doses. There is no increased risk for overdose.
|